PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.24
+1.56 (2.27%)
Jun 4, 2026, 3:11 PM EDT - Market open
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $5.83 billion as of June 4, 2026. Its market cap has increased by 56.54% in one year.
Market Cap
5.83B
Enterprise Value
6.69B
1-Year Change
56.54%
Ranking
Category
Stock Price
$70.24
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $5.83B, an increase of 1,491.03%. That is a compound annual growth rate of 23.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 5.70B | -6.59% |
| Dec 31, 2025 | 6.10B | 75.18% |
| Dec 31, 2024 | 3.48B | 67.39% |
| Dec 29, 2023 | 2.08B | -24.20% |
| Dec 30, 2022 | 2.74B | -2.56% |
| Dec 31, 2021 | 2.82B | -32.38% |
| Dec 31, 2020 | 4.16B | 40.68% |
| Dec 31, 2019 | 2.96B | 70.95% |
| Dec 31, 2018 | 1.73B | 150.23% |
| Dec 29, 2017 | 692.00M | 84.83% |
| Dec 30, 2016 | 374.40M | -66.28% |
| Dec 31, 2015 | 1.11B | -36.17% |
| Dec 31, 2014 | 1.74B | 311.45% |
| Dec 31, 2013 | 422.80M | 15.46% |
| Jun 20, 2013 | 366.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.45B |
| Centessa Pharmaceuticals | 6.17B |
| Spyre Therapeutics | 6.13B |
| Protagonist Therapeutics | 6.10B |
| Rhythm Pharmaceuticals | 6.02B |
| Celcuity | 6.00B |
| Cogent Biosciences | 5.95B |
| Apogee Therapeutics | 5.94B |